Vietnam Medicinal (Vietnam) Performance
| DVM Stock | 7,900 300.00 3.95% |
The entity has a beta of 0.2, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Vietnam Medicinal's returns are expected to increase less than the market. However, during the bear market, the loss of holding Vietnam Medicinal is expected to be smaller as well. At this point, Vietnam Medicinal has a negative expected return of -0.38%. Please make sure to validate Vietnam Medicinal's jensen alpha, accumulation distribution, relative strength index, as well as the relationship between the value at risk and day typical price , to decide if Vietnam Medicinal performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Vietnam Medicinal Materials has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Vietnam |
Vietnam Medicinal Relative Risk vs. Return Landscape
If you would invest 1,010,000 in Vietnam Medicinal Materials on September 1, 2024 and sell it today you would lose (220,000) from holding Vietnam Medicinal Materials or give up 21.78% of portfolio value over 90 days. Vietnam Medicinal Materials is producing return of less than zero assuming 1.5648% volatility of returns over the 90 days investment horizon. Simply put, 13% of all stocks have less volatile historical return distribution than Vietnam Medicinal, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Vietnam Medicinal Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vietnam Medicinal's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vietnam Medicinal Materials, and traders can use it to determine the average amount a Vietnam Medicinal's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.241
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DVM |
Estimated Market Risk
| 1.56 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.38 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vietnam Medicinal is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vietnam Medicinal by adding Vietnam Medicinal to a well-diversified portfolio.
Things to note about Vietnam Medicinal performance evaluation
Checking the ongoing alerts about Vietnam Medicinal for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vietnam Medicinal help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vietnam Medicinal generated a negative expected return over the last 90 days |
- Analyzing Vietnam Medicinal's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vietnam Medicinal's stock is overvalued or undervalued compared to its peers.
- Examining Vietnam Medicinal's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vietnam Medicinal's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vietnam Medicinal's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vietnam Medicinal's stock. These opinions can provide insight into Vietnam Medicinal's potential for growth and whether the stock is currently undervalued or overvalued.